IP Library Patent Application 15820931
Patent Application
App. No. 15/820,931

HYPOCHLOROUS ACID-BASED HAND SANITIZER

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/820,931
Abstract

A sanitizing formulation is disclosed for use as a hand sanitizer. The formulation may include hypochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the sanitizing formulation are also disclosed.

Claims (23)

1 . A method of disinfecting a surface, comprising:

applying to the surface a sanitizing formulation comprising hypochlorite.

2 . The method of claim 1 , wherein the surface is skin.

3 . The method of claim 1 , wherein the sanitizing formulation further comprises at least one of sodium phosphate or hydrochloric acid, sodium magnesium silicate, and a silicone polymer or blend thereof.

4 . The method of claim 3 , wherein hypochlorite is in an amount of about 75 ppm, wherein the sodium phosphate is in an amount of about 0.2% w/v, wherein the hydrochloric acid is in an amount of about 0.08% w/v, wherein the sodium magnesium silicate is in an amount of about 3% w/v, and wherein the silicone polymer or blend thereof is in an amount of about 3% w/v.

5 . The method of claim 1 , wherein the sanitizing formulation further comprises water, buffer, or combinations thereof.

6 . The method of claim 1 , wherein the applying comprises killing at least one superbug.

7 . The method of claim 6 , wherein the at least one superbug is selected from the group consisting of Staphylococcus aureus (including methicillin-resistant S. aureus (MRSA) and vancomycin-resistant S. aureus (VRSA)), extended spectrum beta-lactamase (ESBL), Pseudomonas aeruginosa, Clostridium difficile, Salmonella, Mycobacterium tuberculosis, Escherichia coli (including Carbapenem resistant E. coli ), multidrug-resistant Acinetobacter baumannii (MRAB), vancomycin-resistant Enterococcus (VRE), Carbapenem resistant Klebsiella pneumoniae, HIV, hepatitis, and influenza.

8 . A sanitizing formulation, comprising:

hypochlorous acid;

sodium phosphate or hydrochloric acid;

sodium magnesium silicate; and

a silicone polymer or blend thereof.

9 . The formulation of claim 8 , wherein the hypochlorous acid is present in an amount of about 50 to about 200 ppm.

10 . The formulation of claim 8 , wherein the sodium phosphate is present in an amount of about 0.1 to about 0.5% w/v.

11 . The formulation of claim 8 , wherein the hydrochloric acid is present in an amount of about 0.01% to about 15% w/v.

12 . The formulation of claim 8 , wherein the sodium magnesium silicate is present in an amount of 0 to about 5% w/v.

13 . The formulation of claim 8 , wherein the silicone polymer or blend thereof comprises a blend of dimethicone and cyclomethicone.

14 . The formulation of claim 8 , wherein the silicone polymer or blend thereof is present in an amount of about 1 to about 20% w/v.

15 . The formulation of claim 8 , wherein the hypochlorous acid is in an amount of about 75 ppm, wherein the sodium phosphate is in an amount of about 0.2% w/v, wherein the sodium magnesium silicate is in an amount of about 3% w/v, and wherein the silicone polymer or blend thereof is in an amount of about 3% w/v.

16 . The formulation of claim 8 , wherein the hypochlorous acid is in an amount of about 75 ppm, wherein the hydrochloric acid is in an amount of about 0.08% w/v, wherein the sodium magnesium silicate is in an amount of about 3% w/v, and wherein the silicone polymer or blend thereof is in an amount of about 3% w/v.

17 . The formulation of claim 8 , wherein the pH is in the range from 6.5-7.8.

18 . The formulation of claim 8 , further comprising water, buffer, or combinations thereof.

Assignments (2)
CHANGE OF NAME Recorded Jul 24, 2018
From: REOXCYN INNOVATION GROUP, LLC
To: REOXCYN, LLC.
Reel/Frame 046620/0800 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: REOXCYN DISCOVERIES GROUP, INC.
To: REOXCYN INNOVATION GROUP, LLC
Reel/Frame 044783/0981 →